<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Lumenisvision - Latest News</title>
<link href="https://news.prfree.org/rss/lumenisvision/latest.xml"></link>
<updated>2026-07-22T19:05:55+00:00</updated>
<id>urn:uuid:ed2b8052-4c15-7549-fbc3-d7b8cfbbbb44</id>
<entry>
<title>Ojas Eye Hospital introduces Lumenis M22 OPT technology for dry eyes</title>
<link href="https://news.prfree.org/@lumenisvision/ojas-eye-hospital-introduces-lumenis-m22-opt-technology-for-dry-eyes-abkq6bw8xmqw"></link>
<id>urn:uuid:9e0a7aa2-e319-86e5-a4ec-b3eb2657d748</id>
<summary type="html"><![CDATA[The Lumenis M22 OPT is an excellent technology for treating eyelid inflammation. OPT is selectively absorbed in the hemoglobin of abnormal blood vessels, and destroys them by thrombolysis.]]></summary>
<updated>2018-08-07T09:43:47+00:00</updated>
</entry>
</feed>